These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38057121)

  • 1. Organizational Strategies to Promote Well-Being and Combat Burnout in Rheumatology: Comment on the article by Calabrese et al.
    Iyer P; Kumar B
    Arthritis Rheumatol; 2024 Apr; 76(4):662-663. PubMed ID: 38057121
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatology is exiting the age of "can we" (we certainly can) and now must entertain the question "should we?": comment on the article by Mosor et al.
    Rothschild BM
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1340-1341. PubMed ID: 32374935
    [No Abstract]   [Full Text] [Related]  

  • 3. On telemedicine in rheumatology, with a pedagogical implementation from rural Oklahoma: comment on the article by Lockwood et al.
    Kaushik P; Bastible S; Marak C
    Arthritis Care Res (Hoboken); 2023 Jun; 75(6):1385-1386. PubMed ID: 36303521
    [No Abstract]   [Full Text] [Related]  

  • 4. Further Investigation of Representation of Women as Authors of Rheumatology Articles From 2005 to 2020: Comment on the Article by Bagga et al.
    Velasco J; Singla S; Putman M; Thorgerson AA; Suelzer E; Crayne CB
    Arthritis Rheumatol; 2021 Mar; 73(3):546-547. PubMed ID: 33142027
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the 2020 American College of Rheumatology Guideline for the Management of Gout: Comment on the Article by FitzGerald et al.
    Lipsky PE; Edwards NL; Fields TR; Keenan RT; Mandell BF; Schlesinger N
    Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1506-1507. PubMed ID: 32702211
    [No Abstract]   [Full Text] [Related]  

  • 6. 2019 update of the American College of Rheumatology- recommended rheumatoid arthritis disease activity measures: comment on the article by England et al.
    Fleischmann R
    Arthritis Care Res (Hoboken); 2020 May; 72(5):736. PubMed ID: 32004413
    [No Abstract]   [Full Text] [Related]  

  • 7. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Comment on the Article by Buckley et al.
    Maricic M; Deal C; Dore R; Laster A
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):949-950. PubMed ID: 28941168
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of sarcoidosis in US rheumatology practices: comment on the article by Hamman et al.
    Yee AMF
    Arthritis Care Res (Hoboken); 2022 Dec; 74(12):2119-2120. PubMed ID: 35695770
    [No Abstract]   [Full Text] [Related]  

  • 9. The Use of Low-Dose Oral Glucocorticoids Was Minimized in the 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: Comment on the Article by Singh et al.
    Conn DL
    Arthritis Care Res (Hoboken); 2016 May; 68(5):722. PubMed ID: 26866710
    [No Abstract]   [Full Text] [Related]  

  • 10. The Use of Low-Dose Oral Glucocorticoids Was Minimized in the 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: Comment on the Article by Singh et al.
    Conn DL
    Arthritis Rheumatol; 2016 May; 68(5):1314. PubMed ID: 26866310
    [No Abstract]   [Full Text] [Related]  

  • 11. Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.
    Graudal N; Jürgens G
    Arthritis Care Res (Hoboken); 2013 May; 65(5):832. PubMed ID: 23097263
    [No Abstract]   [Full Text] [Related]  

  • 12. American College of Rheumatology treatment guidelines continue to omit guidance on glucocorticoids: comment on the article by Singh et al.
    Boers M; Kirwan JR; Bijlsma JW
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1622. PubMed ID: 22740377
    [No Abstract]   [Full Text] [Related]  

  • 13. The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et al.
    Calabrese LH; Calabrese C; Kirchner E
    Arthritis Care Res (Hoboken); 2016 May; 68(5):723-4. PubMed ID: 26866816
    [No Abstract]   [Full Text] [Related]  

  • 14. The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et al.
    Calabrese LH; Calabrese C; Kirchner E
    Arthritis Rheumatol; 2016 May; 68(5):1314-5. PubMed ID: 26866423
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.
    Yazici H; Ozguler Y; Hatemi G; Yazici Y
    Arthritis Rheumatol; 2016 May; 68(5):1315-6. PubMed ID: 26867149
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.
    Yazici H; Ozguler Y; Hatemi G; Yazici Y
    Arthritis Care Res (Hoboken); 2016 May; 68(5):724. PubMed ID: 26866613
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.
    Conn DL
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1622-3; author reply 1623-4. PubMed ID: 23024030
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402.
    Cohen JD; Tropé S; Munos A; Bocquet F
    Joint Bone Spine; 2019 Mar; 86(2):287-288. PubMed ID: 30394338
    [No Abstract]   [Full Text] [Related]  

  • 19. Why is methotrexate the first selection in disease-modifying antirheumatic drug therapy? Comment on the article by Wolfe et al.
    Caballero-Uribe CV
    Arthritis Care Res; 1999 Apr; 12(2):152. PubMed ID: 10513503
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Nakano K et al.
    Urata Y
    Mod Rheumatol; 2023 Apr; 33(3):631. PubMed ID: 36350185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.